<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Alivus Life Sciences Ltd — News on 6ix</title>
    <link>https://6ix.com/company/alivus-life-sciences-limited</link>
    <description>Latest news and press releases for Alivus Life Sciences Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 14 May 2026 14:29:53 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/alivus-life-sciences-limited" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836496e78dffbe2df152841.webp</url>
      <title>Alivus Life Sciences Ltd</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited</link>
    </image>
    <item>
      <title>Press Release May 14 2026</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-may-14-2026-9</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-may-14-2026-9</guid>
      <pubDate>Thu, 14 May 2026 14:29:53 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated May 14, 2026, titled &quot;Press Release of the Company for the fourth quarter and year ended March 31, 2026.&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 22 2026</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-22-2026-20</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-22-2026-20</guid>
      <pubDate>Thu, 22 Jan 2026 19:23:09 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 22, 2026, titled &quot;Press Release on Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2025.&quot;.</description>
    </item>
    <item>
      <title>Press Release Nov 06 2025</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-nov-06-2025-27</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-nov-06-2025-27</guid>
      <pubDate>Thu, 06 Nov 2025 23:55:31 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated November 06, 2025, titled &quot;Press Release - Q2 FY2026 Financials.&quot;.</description>
    </item>
    <item>
      <title>Press Release Aug 01 2025</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-aug-01-2025-21</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-aug-01-2025-21</guid>
      <pubDate>Fri, 01 Aug 2025 23:10:53 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated August 01, 2025, titled &quot;Press Release of the Company for the First Quarter ended June 30, 2025.&quot;.</description>
    </item>
    <item>
      <title>Press Release May 15 2025</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-may-15-2025-19</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-may-15-2025-19</guid>
      <pubDate>Fri, 16 May 2025 00:58:19 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated May 15, 2025, titled &quot;Press Release&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 23 2025</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-23-2025-16</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-23-2025-16</guid>
      <pubDate>Thu, 23 Jan 2025 19:31:19 GMT</pubDate>
      <description>Alivus Life Sciences Limited has informed the Exchange regarding a press release dated January 23, 2025, titled &quot;Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 18 2025</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-18-2025-8</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-18-2025-8</guid>
      <pubDate>Sat, 18 Jan 2025 18:53:28 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 18, 2025, titled &quot;Glenmark Life Sciences rebrands as Alivus Life Sciences&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 24 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-oct-24-2024-22</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-oct-24-2024-22</guid>
      <pubDate>Thu, 24 Oct 2024 23:26:29 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated October 24, 2024, titled &quot;Press Release&quot;.</description>
    </item>
    <item>
      <title>Press Release Jul 25 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jul-25-2024-19</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jul-25-2024-19</guid>
      <pubDate>Thu, 25 Jul 2024 23:50:45 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2024, titled &quot;Press Release on the Unaudited Financial Results of the Company for the First Quarter ended June 30, 2024&quot;.</description>
    </item>
    <item>
      <title>Press Release Apr 25 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-apr-25-2024-18</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-apr-25-2024-18</guid>
      <pubDate>Thu, 25 Apr 2024 18:59:07 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated April 25, 2024, titled &quot; Press Release of the Company for the Fourth Quarter and Year ended March 31, 2024.&quot;.</description>
    </item>
    <item>
      <title>Press Release Mar 12 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-mar-12-2024-5</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-mar-12-2024-5</guid>
      <pubDate>Tue, 12 Mar 2024 23:47:03 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated March 12, 2024, titled &quot;Nirma Limited acquires majority stake in Glenmark Life Sciences&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 23 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-23-2024-18</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-23-2024-18</guid>
      <pubDate>Tue, 23 Jan 2024 22:33:36 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 23, 2024, titled &quot;Press release on Q3 FY24 and 9M FY24 Results&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 19 2024</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-19-2024-10</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jan-19-2024-10</guid>
      <pubDate>Fri, 19 Jan 2024 14:47:32 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated January 19, 2024, titled &quot;Glenmark Life Sciences Signs Master Supply Agreement with a leading Japanese innovator pharmaceutical company&quot;.</description>
    </item>
    <item>
      <title>Press Release Oct 20 2023</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-oct-20-2023-24</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-oct-20-2023-24</guid>
      <pubDate>Fri, 20 Oct 2023 17:22:03 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated October 20, 2023, titled &quot;Press Release and Management Discussion &amp; Analysis&quot;.</description>
    </item>
    <item>
      <title>Press Release Jul 21 2023</title>
      <link>https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jul-21-2023-11</link>
      <guid isPermaLink="true">https://6ix.com/company/alivus-life-sciences-limited/news/press-release-jul-21-2023-11</guid>
      <pubDate>Fri, 21 Jul 2023 17:08:11 GMT</pubDate>
      <description>Glenmark Life Sciences Limited has informed the Exchange regarding a press release dated July 21, 2023, titled &quot;Press Release and Management Discussion &amp; Analysis of the Company for the First Quarter ended June 30, 2023.&quot;.</description>
    </item>
  </channel>
</rss>